Influence of the 3D-sonographic Representation of the Fetal Face on the Health-conscious Behavior of Pregnant Women
Launched by MARTIN-LUTHER-UNIVERSITÄT HALLE-WITTENBERG · Mar 23, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how seeing a 3D image of a baby's face during ultrasound scans might affect how pregnant women take care of themselves and their babies. Previous research has shown that regular ultrasound exams can help reduce anxiety and stress for expectant mothers, but it's not yet clear if looking at a detailed, 3D image of their baby's face can have a long-lasting positive impact on their behavior and connection with their child.
To participate in this study, women must be pregnant and scheduled for an ultrasound. Women under 18 years old will not be included. While the trial is not yet recruiting participants, those who join can expect to learn more about the potential benefits of 3D imaging and how it might influence their health choices during pregnancy. This research could provide valuable insights into how modern technology can help improve maternal behavior and overall health during this important time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women undergoing ultrasound
- Exclusion Criteria:
- • age \<18 years
About Martin Luther Universität Halle Wittenberg
Martin-Luther-Universität Halle-Wittenberg (MLU) is a prestigious research institution located in Halle, Germany, renowned for its commitment to advancing scientific knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, MLU emphasizes rigorous research methodologies and ethical standards, fostering collaboration among interdisciplinary teams to address critical health challenges. The university's extensive network of researchers and clinicians enables the development and execution of high-quality clinical trials aimed at improving patient outcomes and contributing to the global body of medical research. Through its dedication to excellence, MLU plays a pivotal role in translating scientific discoveries into tangible healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Marcus Riemer, MD
Principal Investigator
University Hospital of Halle
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported